logo
Select company
Select metric
-45.83%Buyback Yield
VS
Market
6
Sector
17
Industry
21
History
9
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-45.83%$ 274.06M$ 125.61M
3/31/2025-46.46%$ 270.44M$ 125.65M
12/31/2024-29.86%$ 430.32M$ 128.49M
9/30/2024-24.17%$ 528.12M$ 127.64M
6/30/2024-1.17%$ 275.19M$ 3.23M
3/31/2024-0.75%$ 413.76M$ 3.11M
12/31/2023-0.22%$ 104.25M$ 231K
9/30/2023-0.17%$ 136.77M$ 231K
6/30/2023-0.44%$ 171.84M$ 761K
3/31/2023-22.93%$ 164.17M$ 37.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -24.09%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Buyback Yield has been -16.58%.
  • The median Buyback Yield for CARTESIAN THERAPEUTICS INC during this period was -16.12%
  • CARTESIAN THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at -0.17%.
  • The lowest Buyback Yield recorded by CARTESIAN THERAPEUTICS INC in the same timeframe -46.46%

CARTESIAN THERAPEUTICS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
HUMA : HUMACYTE INC -37.45%NWBO : NORTHWEST BIOTHERAPEUTICS INC -6.78%MREO : MEREO BIOPHARMA GROUP PLC 0.13%INBX : INHIBRX BIOSCIENCES INC 0%CRDF : CARDIFF ONCOLOGY INC -23.44%BTAI : BIOXCEL THERAPEUTICS INC -20.83%CATX : PERSPECTIVE THERAPEUTICS INC -3.93%ADVM : ADVERUM BIOTECHNOLOGIES INC -0.69%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -29.12%LSTA : LISATA THERAPEUTICS INC -1.35%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for CARTESIAN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 84.3M ]) / Market Cap [ $ 350.02M ]
(=) Buyback Yield [ -24.09% ]

RNAC - Buyback Yield, Last 5 years

-46.46%

Minimum

Mar 31, 2025

-0.17%

Maximum

Sep 30, 2023

-16.58%

Average

-16.12%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%